Research summary, narrative review, 2014

Non-fluoroscopic catheter visualization using MediGuide technology: experience from the first 600 procedures

Sommer P, Richter S, Hindricks G, Rolf S. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing. 2014

Read the original paper

In plain language

In electrophysiology ablations and cardiac resynchronization therapy (CRT) implants, including over 600 procedures at one centre, a sensor-based catheter tracking system was linked to large reductions in fluoroscopy time, with efficacy reported as similar. Effects on the fluoroscopy team's dose were not measured.

At a glance

Type of study
Narrative review, Case report or series
Who was studied
Electrophysiologists, Patients
Size
n = 600 procedures
Summary based on
the abstract

What it found

  • For supraventricular tachycardia (SVT) ablation, fluoroscopy time with MediGuide was far lower than with conventional fluoroscopic settings.

    Key figures: 0.5 ± 1.4 min vs 10.2 ± 9.6 min

  • For atrial fibrillation (AF) ablation, fluoroscopy time fell from 25 min with electroanatomical mapping and live x-ray to 4.6 min with MediGuide added.

    Key figures: 25 min to 4.6 min

  • Using MediGuide for CRT implants gave a median fluoroscopy time of 2.6 min for LV lead deployment.

    Key figures: median 2.6 min

  • The authors report that fluoroscopy was reduced without negative effects on efficacy, complications or procedure time in more than 600 electrophysiology (EP) procedures.

    Key figures: >600 procedures

Limits to keep in mind

A narrative review combined with an uncontrolled single-centre experience report; most figures come from cited studies and no comparative data from the 600 procedures are given. Fluoroscopy time is a surrogate and staff dose was not measured.

How this summary was made

ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.